{"name":"InFlectis BioScience","slug":"inflectis-bioscience","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPZzhzNUV4V0FldDBxX1FvMzZhOEJoTzdlbUxyb3Jpc3dIMDFsX3NrM2ZIc1NNLTBKR0dmcVZ4ZmotRWREY0RVdEZ4ZXY2Z2h2X29aMGMwbHcyVUlDSV9JakU0YTdmSWFHdE1sOUxhR3Q3M2swa3V3cy05dEtUbHA0OTdPMVBac2ZBMWZ6dTMwT0x0RmN2NHc?oc=5","date":"2026-04-01","type":"pipeline","source":"openPR.com","summary":"Charcot-Marie-Tooth (CMT) Disease Market Size to Reach US$ - openPR.com","headline":"Charcot-Marie-Tooth (CMT) Disease Market Size to Reach US$","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQV19SSmJGenRyTUxPR0twOHlwei1YNTVYUWNYVi1NaGoxU3NpYUdLQjNpamFnR3lKN3JXelRkeHdFWWdDeGRHUkg4YmNkcHFjLWhUNDJlVW5fX0xtQW1VUnVVdHA0d1l2X3RhTDNmUHJqUl9UUTJqZEpBVzdhLTI5SEVsS3lsODNxUG04OWdfUDE4T0hvMk9xUkVqaVNPd0dSOTMxb3U4YTZXTEttQ280SXRvek1uekJfVmZLYTFJWERNYkhoX0hyaWxHMm1Zcl9jcW1fekFyZ3I3MzNWbjlFVThCZG5aMHNDV1I3czZyZ19QZGR2cmlaNXJFSE9KVV9TejdEYXZaUEN3S1ZMNkNnR0JLSnFabXJMY3RIZmttTWx1MXVmZ0hLS0MwdE9aU2lxR2ZwajlqMG9mRzhFSEgwUw?oc=5","date":"2025-12-09","type":"pipeline","source":"prnewswire.com","summary":"Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight - prnewswire.com","headline":"Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPY09DS2tLRTVhTk5BbkdwdGhFZVA0WE9ZUlcxZDNrT3NoaWRMZVdfSEFvME5qSmdBRlEyXzE0cjFYSUFlVzk3R2dwU0NXRnZCQXQweVZYdjN3aWtpNFRkd01iYnBiWW9KeTcyalR2Q3pQX2Y5cEE3TTVMSDJjMXBwWlJENDZGNWJwbHFRSmFGekltSmpyeUZIdDFha29iUmx4NW9MNXFR?oc=5","date":"2025-07-02","type":"trial","source":"Yahoo Finance","summary":"InFlectis BioScience Announces Publication of Groundbreaking Study on IFB-088's Therapeutic Potential in ALS in Life Science Alliance - Yahoo Finance","headline":"InFlectis BioScience Announces Publication of Groundbreaking Study on IFB-088's Therapeutic Potential in ALS in Life Sci","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOejR2TWJXV3VsaEZuSUdjdUIxMldqV3QxYUJEYXNqSDJCX2F5eFUwbXJBQ1BkRlFxS196QUNWZDljUkd0QWg0a1J1QzdSbmk0dVJyVE9MSUhET2ZDQ3BBcElaVG5ZS3JHa0xvOEthLW9QSUpuX1Z1dll4REZ6TVQyWTVwQXBoclpMVUlNa1l6Z2VUM3JwT0NaT0dmODdUbVpGZENVQm0wb3g4cVVTZFJjRk5qM085dDJDYUpxc1A2bndVSWo1aXNWQnVQa2R4aW1USXJHQzN0NHdsS0lTemRvVnVIcGFhZ0IzRHNjSnpLdw?oc=5","date":"2025-02-06","type":"trial","source":"BioSpace","summary":"InFlectis BioScience Announces Promising Results for IFB-088 in a Phase 2a Clinical Study in Bulbar-Onset ALS Patients - BioSpace","headline":"InFlectis BioScience Announces Promising Results for IFB-088 in a Phase 2a Clinical Study in Bulbar-Onset ALS Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPc0ZRc1F0cUhrY0RVdTczMUhmOUtCaC1JcGs4dGpEUEVrWmFpOGM1VURoNldNWEd5WXJhM1BTTXBJaVlBOUVJcmd5WHdPWjZiVWxuNWFMdUh0RUFkLUM0RG5sRl8yNjBMcHBBQnBkdzRDZGVVMnc2MjRKeTVmbTdWLVZOaF93Z2s?oc=5","date":"2023-09-18","type":"pipeline","source":"Yahoo Finance","summary":"Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH, ENCell, InFlectis, Addex, Augustine, DTx Pharma - Ya","headline":"Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxPTnRsNkVhTUh5aVFQUW56NkNWTVJGYzVqM3JvWmxyT2l6SFNGd2s5SGY3NWZHYnhFN3pvU2M3T0tJVEJ5MHVmOHUxVk5TV2RrT0VaM3Q4NjcyaU5ZZHhrQ0Rxa1BUYmVXb0NhUkFtMGM4LV9LdDd0ZFVzQ1ZyYnVnQ2d2Y3ZYenVOR3FRS2t3ME1Xbm1mUzFkSVhMd29MM09ZUXFGRVZGcHVrc0pWbUdBdk5veGdfR1NoQzFZNXdkSzVjV25Ka0pzZXpNVi1YV3ZzQ3A3aGllWWpFTVJoTzZvX2g4V290VFBDbWZUT2g2YjkwVnl4?oc=5","date":"2022-03-28","type":"pipeline","source":"BioSpace","summary":"InFlectis BioScience Granted Orphan Drug Designation for IFB-088 (icerguastat), a Clinical Stage Treatment for Amyotrophic Lateral Sclerosis - BioSpace","headline":"InFlectis BioScience Granted Orphan Drug Designation for IFB-088 (icerguastat), a Clinical Stage Treatment for Amyotroph","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-10-04","type":"regulatory","source":"TMX Newsfile","summary":"InFlectis BioScience Expands Leadership Team with Three Experienced International Appointments: Mark Pykett Is Appointed Chairman, Béatrice Lejeune Is Appointed Chief Regulatory Officer, and Prof. Bri","headline":"InFlectis BioScience Expands Leadership Team with Three Experienced International Appointments: Mark Pykett Is Appointed","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}